Page last updated: 2024-08-21

aminoimidazole carboxamide and Leukemia, Promyelocytic, Acute

aminoimidazole carboxamide has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bedalov, A; Dembitz, V; Kodvanj, I; Simon, JA; Tomic, B; Visnjic, D	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Leukemia, Promyelocytic, Acute

Article	Year
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion. The Journal of biological chemistry, 2019, 10-18, Volume: 294, Issue:42 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Differentiation; Cell Line, Tumor; Checkpoint Kinase 1; Dihydroorotate Dehydrogenase; Humans; Leukemia, Promyelocytic, Acute; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidines; Ribonucleosides; S Phase Cell Cycle Checkpoints	2019

Article

Year

The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion.

The Journal of biological chemistry, 2019, 10-18, Volume: 294, Issue:42

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Differentiation; Cell Line, Tumor; Checkpoint Kinase 1; Dihydroorotate Dehydrogenase; Humans; Leukemia, Promyelocytic, Acute; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidines; Ribonucleosides; S Phase Cell Cycle Checkpoints

2019